Renaissance Technologies’s Acumen Pharmaceuticals ABOS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $286K | Sell |
246,588
-10,112
| -4% | -$11.7K | ﹤0.01% | 3060 |
|
2025
Q1 | $282K | Sell |
256,700
-513
| -0.2% | -$564 | ﹤0.01% | 2943 |
|
2024
Q4 | $442K | Sell |
257,213
-48,887
| -16% | -$84.1K | ﹤0.01% | 2899 |
|
2024
Q3 | $759K | Sell |
306,100
-32,000
| -9% | -$79.4K | ﹤0.01% | 2597 |
|
2024
Q2 | $818K | Buy |
+338,100
| New | +$818K | ﹤0.01% | 2437 |
|
2023
Q4 | – | Sell |
-87,400
| Closed | -$363K | – | 3686 |
|
2023
Q3 | $363K | Buy |
87,400
+42,600
| +95% | +$177K | ﹤0.01% | 2852 |
|
2023
Q2 | $215K | Buy |
44,800
+7,355
| +20% | +$35.3K | ﹤0.01% | 3273 |
|
2023
Q1 | $152K | Buy |
37,445
+5,145
| +16% | +$20.9K | ﹤0.01% | 3368 |
|
2022
Q4 | $174K | Buy |
+32,300
| New | +$174K | ﹤0.01% | 3469 |
|
2022
Q1 | – | Sell |
-21,609
| Closed | -$146K | – | 4035 |
|
2021
Q4 | $146K | Buy |
+21,609
| New | +$146K | ﹤0.01% | 3612 |
|